HC Wainwright Issues Pessimistic Forecast for LENZ Earnings
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a research report issued to clients and investors on Thursday, May 8th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings per share […]
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a research report issued to clients and investors on Thursday, May 8th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings per share […]
